CD Private Equity Fund III Fundamental Analysis
CD Private Equity Fund III (CD3.AX) shows moderate financial fundamentals with a PE ratio of -7.67, profit margin of 14.72%, and ROE of -7.49%. The company generates $-0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 41.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CD3.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakCD3.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCD3.AX trades at attractive valuation levels.
Growth Score
WeakCD3.AX faces weak or negative growth trends.
Financial Health Score
ExcellentCD3.AX maintains a strong and stable balance sheet.
Profitability Score
WeakCD3.AX struggles to sustain strong margins.
Key Financial Metrics
Is CD3.AX Expensive or Cheap?
P/E Ratio
CD3.AX trades at -7.67 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CD3.AX's PEG of 0.05 indicates potential undervaluation.
Price to Book
The market values CD Private Equity Fund III at 0.60 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -7.97 times EBITDA. This is generally considered low.
How Well Does CD3.AX Make Money?
Net Profit Margin
For every $100 in sales, CD Private Equity Fund III keeps $14.72 as profit after all expenses.
Operating Margin
Core operations generate 15.86 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-7.49 in profit for every $100 of shareholder equity.
ROA
CD Private Equity Fund III generates $-7.55 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CD Private Equity Fund III generates strong operating cash flow of $-386.80K, reflecting robust business health.
Free Cash Flow
CD Private Equity Fund III generates strong free cash flow of $-386.80K, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $-0.01 in free cash annually.
FCF Yield
CD3.AX converts -0.56% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-7.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.60
vs 25 benchmark
P/S Ratio
Price to sales ratio
-112.89
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
62.89
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.07
vs 25 benchmark
ROA
Return on assets percentage
-0.08
vs 25 benchmark
ROCE
Return on capital employed
-0.08
vs 25 benchmark
How CD3.AX Stacks Against Its Sector Peers
| Metric | CD3.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -7.67 | 20.54 | Better (Cheaper) |
| ROE | -7.49% | 619.00% | Weak |
| Net Margin | 1471.69% | -8973.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 1.50 | Strong (Low Leverage) |
| Current Ratio | 62.89 | 932.90 | Strong Liquidity |
| ROA | -7.55% | -839.00% (disorted) | Weak |
CD3.AX outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CD Private Equity Fund III's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical